AdvaMed launched a Strategic Value Initiative to develop principles and an approach for assessing the value of medical technologies that can be adopted by medtech companies, health systems, payers, and…
It is critical for diagnostic test developers to demonstrate the value of their tests to a variety of stakeholders. This framework serves as a resource for members to assess and…
Investment in early-stage medtech innovation can be critical in ensuring that patients have access to novel therapeutics and diagnostics.
Medical devices can offer important therapeutic advances but, as for any medical interventions, there are questions about their costs and benefits.
This report provides a 2021 statistical update on the contributions of the medical technology industry to national and state economic conditions.
To understand where medtech companies stand in fulfilling this objective, Deloitte and AdvaMed conducted a benchmarking analysis of data from 20 medtech company business units.
This study was engaged to develop estimates of medical device spending in the United States, compare our estimates to NHE estimates published by CMS, and develop estimates of price changes…
This study aimed to verify whether the medical technology available in the Brazilian market is, in fact, becoming more expensive and increasing healthcare costs.
This report focuses on ways to modernize Medicare’s payment and coverage policies.
The objective of this study is to assess the potential impact of pricing regulation of medical devices in Brazil, China, Colombia and India.